Imilia Ismail

12PUBLICATIONS
21CO-AUTHORS
Metabolic medicineTumour immunologyMolecular targetsHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
Screening and Stratification Utility of GDF-15 and FGF-21 in Individuals Evaluated for Suspected Mitochondrial Disease: A Malaysian Cohort Study.

|Jul 21, 2025
Immunotherapy and combination treatments for triple-negative breast cancer: a Scopus bibliometric perspective.

Ninie Nadia Zulkipli, Imilia Ismail, Wan Rohani Wan Taib

|Jun 28, 2023
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway.

Futoon Abedrabbu Al-Rawashde, Ola M Al-Sanabra, Moath Alqaraleh

|Apr 13, 2023
HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia.

Hanan Kamel M Saad, Wan Rohani Wan Taib, Azly Sumanty Ab Ghani

|Sep 23, 2022
Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.

Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-Wajeeh, Mansoureh Nazari Vishkaei

|Jul 09, 2022
MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance.

Rashidah Baharudin, Nurul Qistina Rus Bakarurraini, Imilia Ismail

Pageof 2

Frequent Collaborators

8 joint publications

Hamid Ali Nagi Al-Jamal

7 joint publications

Muhammad Farid Johan

6 joint publications

Abdullah Saleh Al-Wajeeh

4 joint publications

Futoon Abedrabbu Al-Rawashde